google-site-verification: googlec7193c3de77668c9.html

New study could improve testing and treatment for rare brain, spinal cord, and eye cancers

[
A new study has identified hepatitis A virus cellular receptor 1 (HAVCR1) as a biomarker that could make it easier to diagnose rare but aggressive forms of brain and eye cancer earlier and with fewer invasive tests.


Source link

Advertisements
Views: 1

See also  Blood fat profiles confirm health benefits of replacing butter with high-quality plant oils